Fabio Ciceri
I.R.C.C.S. Ospedale San Raffaele · IRCCS Ospedale San Raffaele · IRCCS San Raffaele
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Fabio Ciceri as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 04:48 UTC. Open this list on ClinicalTrials.gov
- Ph1/Ph2NCT05768035 · Safety and Efficacy of SMART101 in Adult Patients With Hematological Malignancies After Haploidentical HSCT With Post-transplant CyclophosphamideSmart Immune SAS · unknown · Hematological Malignancies · principal investigator
- N/ANCT05124288 · Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic PathwaysCiceri Fabio · recruiting · Acute Myeloid Leukemia, in Relapse · principal investigator
- Ph1/Ph2NCT04097301 · Study of CAR T-cell Therapy in Acute Myeloid Leukemia and Multiple MyelomaAGC Biologics S.p.A. · terminated · Acute Myeloid Leukemia, Multiple Myeloma · principal investigator
- Ph2NCT03961919 · Phase II Trial in Elderly Patients With AML or MDS in Complete Remission Not Eligible for Allogenic TransplantCiceri Fabio · completed · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Transplant-Related Hematologic Malignancy · principal investigator
- Ph1/Ph2NCT03875495 · A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)Genenta Science · terminated · Multiple Myeloma · principal investigator
- Ph2NCT03610438 · Feasibility and Effectiveness of Inotuzumab Ozogamicin in B-Cell Acute Lymphoblastic LeukemiaGruppo Italiano Malattie EMatologiche dell'Adulto · active not recruiting · Acute Lymphoid Leukemia · study director
- Ph2NCT03494959 · Pentaglobin in CRE and PA Neutropenic InfectionsGruppo Italiano Trapianto di Midollo Osseo · active not recruiting · Septic Shock · principal investigator
- Ph2NCT03455504 · Venetoclax Add in Combination With Fludarabine, Cyratabine and Idarubicine in Induction for Acute Myelid LeukemiaGruppo Italiano Malattie EMatologiche dell'Adulto · completed · Acute Myeloid Leukemia · study director
- Ph2NCT03055247 · Combination of Ibuprofen, G-CSF and Plerixafor as Stem Cells Mobilization Regimen in Patients Affected by X-CGDIRCCS San Raffaele · recruiting · Chronic Granulomatous Disease X-linked (X-CGD) · principal investigator
- Ph1/Ph2NCT02453477 · Gene Therapy for Transfusion Dependent Beta-thalassemiaIRCCS San Raffaele · unknown · Beta-Thalassemia · study chair
- Ph2NCT01814488 · A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute LeukemiaGruppo Italiano Trapianto di Midollo Osseo · completed · Acute Leukemia · principal investigator
- Ph1/Ph2NCT00423124 · Infusion of Donor Lymphocytes Transduced With the Suicide Gene HSV TK in Patients With Haematological MalignanciesAGC Biologics S.p.A. · completed · Hematological Malignancies · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 04:48 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 04:48 UTC. The ranking covers the 200 most relevant of 82 PubMed records, and a shared surname and initials can bring in a namesake. All 82 on PubMed
- Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.N Engl J Med · 20131,290 citationsRCR 34.9
- Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.N Engl J Med · 20191,106 citationsRCR 41.3
- Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy.Science · 2013960 citationsRCR 27.4
- Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome.Science · 2013847 citationsRCR 22.6
- Gene therapy for immunodeficiency due to adenosine deaminase deficiency.N Engl J Med · 2009744 citationsRCR 16.1
- 407 citationsRCR 14.3
- 395 citationsRCR 8.1
- 281 citationsRCR 14.8
- COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).J Hematol Oncol · 2021271 citationsRCR 12.8
- 241 citationsRCR 19.4